On Monday, an Oklahoma judge ordered drugmaker Johnson & Johnson to pay $572 million for its involvement in the ongoing opioid crisis—a trial that’s been referred to as a “landmark” case. Because of this suit, we might very well see other pharmaceutical companies, distributors, and even major retailers take…
No comments:
Post a Comment